Lotus Eye Hospital & Institute (BOM:532998) EV-to-FCF: (As of Jul. 28, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532998 Lotus Eye Hospital & Institute Ltd BOM:532998
67 GF Score
Price ₹119.05
GF Value ₹92.27
Valuation Modestly Overvalued
View Full Analysis

What is Lotus Eye Hospital & Institute EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Lotus Eye Hospital & Institute's Enterprise Value is ₹2,595.9 Mil. Lotus Eye Hospital & Institute's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil. Therefore, Lotus Eye Hospital & Institute's EV-to-FCF for today is .

The historical rank and industry rank for Lotus Eye Hospital & Institute's EV-to-FCF or its related term are showing as below:

BOM:532998' s EV-to-FCF Range Over the Past 10 Years
Min: -26.1   Med: 0   Max: 0
Current: -26.1

BOM:532998's EV-to-FCF is ranked worse than
100% of 405 companies
in the Healthcare Providers & Services industry
Industry Median: 17.83 vs BOM:532998: -26.10

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2026-07-28), Lotus Eye Hospital & Institute's stock price is ₹119.05. Lotus Eye Hospital & Institute's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.040. Therefore, Lotus Eye Hospital & Institute's PE Ratio (TTM) for today is 2,976.25.


Lotus Eye Hospital & Institute  (BOM:532998) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Lotus Eye Hospital & Institute's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=119.05/0.040
=2,976.25

Lotus Eye Hospital & Institute's share price for today is ₹119.05.
Lotus Eye Hospital & Institute's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.040.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Lotus Eye Hospital & Institute EV-to-FCF Related Terms


Lotus Eye Hospital & Institute EV-to-FCF Historical Data

* Premium members only.

The historical data trend for Lotus Eye Hospital & Institute's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lotus Eye Hospital & Institute EV-to-FCF Chart

Lotus Eye Hospital & Institute Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -378.17 87.69 2,771.17 -68.05 -22.22

Lotus Eye Hospital & Institute Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -68.05 0.00 0.00 0.00 -22.22

BOM:532998 vs HCA, THC, DVA: EV-to-FCF Comparison

For the Medical Care Facilities subindustry, Lotus Eye Hospital & Institute's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lotus Eye Hospital & Institute EV-to-FCF vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Lotus Eye Hospital & Institute's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Lotus Eye Hospital & Institute's EV-to-FCF falls into.


BOM:532998
67GF Score
Lotus Eye Hospital & Institute Ltd BOM:532998
EV-to-FCF is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Lotus Eye Hospital & Institute EV-to-FCF Calculation

Lotus Eye Hospital & Institute's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2595.874/0
=

Lotus Eye Hospital & Institute's current Enterprise Value is ₹2,595.9 Mil.
Lotus Eye Hospital & Institute's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Is Lotus Eye Hospital & Institute (BOM:532998) Overvalued in 2026?

Based on GuruFocus' analysis, Lotus Eye Hospital & Institute stock appears to be overvalued. The current stock price of ₹119.05 is trading 29% above its estimated GF Value™ of ₹92.27. GuruFocus considers Lotus Eye Hospital & Institute to be Modestly Overvalued.

Key valuation signals for BOM:532998:

  • EV-to-FCF:
  • GF Value™: ₹92.27 vs. price of ₹119.05 (29% above fair value)
  • GF Score™: 67/100

No single metric tells the full story. See the BOM:532998 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lotus Eye Hospital & Institute Business Description

Other Exchanges LOTUSEYE:India
Address SF No. 770/12, Avinashi Road, Civil Aerodrome Post, Coimbatore, TN, IND, 641 014
Lotus Eye Hospital & Institute Ltd is an India-based eye care hospital. It is engaged in providing treatment and care for eye diseases and disorders. It offers treatment services for eye conditions like refractive error, retina and uvea, cornea, glaucoma, pediatric, orbit and oculoplasty, neuro-ophthalmology, and binocular vision. In addition, the company also operates an eye bank for functioning eye donation activities. The company mainly operates in India and generates revenue by providing medical services, pharmacy sales, contact lenses, and optical, of which the majority of the revenue is derived from providing segmmedical services.
67GF Score

Get the complete analysis for BOM:532998

EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹119.05
Price
₹92.27
GF Value